Flutiform 50 µg - 5 µg press. inhal. susp. press. cont.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Fluticasone Propionate 0,05 mg; Sodium Cromoglicate 0,024 mg; Formoterol Fumarate Dihydrate 0,005 mg
Available from:
Mundipharma BV-SRL
ATC code:
R03AK11
INN (International Name):
Fluticasone Propionate; Formoterol Fumarate Dihydrate
Dosage:
50 µg - 5 µg
Pharmaceutical form:
Pressurised inhalation, suspension
Composition:
Fluticasone Propionate 0.05 mg; Formoterol Fumarate Dihydrate 5 µg
Administration route:
Inhalation use
Therapeutic area:
Formoterol and Fluticasone
Product summary:
CTI code: 429405-01 - Pack size: 120 doses - Commercialisation status: YES - FMD code: 05430000958370 - CNK code: 3023363 - Delivery mode: Medical prescription
Authorization status:
Commercialised: Yes
Authorization date:
2012-11-09
